Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of ...

Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, ...

Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.

The medical device supplier said that a threat actor accessed company systems through a social engineering attack.

The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the ...

The program, a partnership with Kinomatic, will use biometric data and care coordination between visits to support recovery ...

We have all this data that’s available, but it’s actually not actionable because we don’t have a way to get it into clinical ...

Zimmer Biomet said Tuesday it has appointed Chintan Desai president of its Asia Pacific region, effective immediately. Desai ...

The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after ...

Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.

The draft agreement outlines the Food and Drug Administration’s goals for medical device reviews from 2028 to 2032.